Korsana Biosciences, Inc. (KRSA): Shareholders' Equity
$9.09M
As of 2025-12-31
$5.09M
As of 2026-06-30
-4.6%
3-year compound annual growth
-31.3%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.09M | +2.7% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $8.85M | -21.6% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $11.29M | +8.0% | 2025-11-12, Balance as of period end |
| 2022-12-31 | $10.45M | -78.3% | 2024-03-05, Balance as of period end |
| 2021-12-31 | $48.25M | -18.9% | 2023-03-22, Balance as of period end |
| 2020-12-31 | $59.49M | -39.1% | 2022-02-24, Balance as of period end |
| 2019-12-31 | $97.73M | n/m | 2021-02-25, Balance as of period end |
| 2018-12-31 | -$10.45M | n/a | 2020-03-12, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | $9.09M | +2.7% |
| Dianthus Therapeutics, Inc. (DNTH) | 2025-12-31 | $493.40M | +40.0% |
| Lipocine Inc. (LPCN) | 2025-12-31 | $14.48M | -31.1% |
| Bio Essence Corp (BIOE) | 2025-12-31 | -$2.07M | n/m |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $3.83M | -24.2% |
| Rani Therapeutics Holdings, Inc. (RANI) | 2025-12-31 | $33.01M | n/m |
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | -$126.24M | n/m |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | $339.77M | -27.7% |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | $7.40M | +23.1% |
Compare KRSA, DNTH, LPCN, BIOE side by side · Screen every company in Pharmaceutical Preparations ↗